Healthcare provider profile · identity verified

Libro Oniboni, DO

Family Practice · SAXONBURG, PA · NPI 1619983509

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	300	66
Lisinopril	Lisinopril	252	61
Losartan Potassium	Losartan Potassium	233	58
Levothyroxine Sodium	Levothyroxine Sodium	197	50
Omeprazole	Omeprazole	188	48
Atorvastatin Calcium	Atorvastatin Calcium	180	46
Meloxicam	Meloxicam	173	39
Rosuvastatin Calcium	Rosuvastatin Calcium	144	39
Simvastatin	Simvastatin	144	37
Hydrochlorothiazide	Hydrochlorothiazide	134	37
Escitalopram Oxalate	Escitalopram Oxalate	123	23
Tramadol Hcl	Tramadol Hcl	118	37
Trazodone Hcl	Trazodone Hcl	117	28
Tamsulosin Hcl	Tamsulosin Hcl	102	30
Sertraline Hcl	Sertraline Hcl	98	28
Metformin Hcl Er	Metformin Hcl	97	23
Pravastatin Sodium	Pravastatin Sodium	95	27
Eliquis	Apixaban	92	13
Metoprolol Tartrate	Metoprolol Tartrate	90	26
Pantoprazole Sodium	Pantoprazole Sodium	87	21
Allopurinol	Allopurinol	82	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	81	17
Clopidogrel	Clopidogrel Bisulfate	80	21
Furosemide	Furosemide	76	17
Gabapentin	Gabapentin	76	21
Montelukast Sodium	Montelukast Sodium	75	15
Albuterol Sulfate Hfa	Albuterol Sulfate	74	32
Ezetimibe	Ezetimibe	72	18
Synthroid	Levothyroxine Sodium	69	18
Tizanidine Hcl	Tizanidine Hcl	69	12
Metoprolol Succinate	Metoprolol Succinate	60	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	57	18
Celecoxib	Celecoxib	54	19
Ozempic	Semaglutide	54	11
Lorazepam	Lorazepam	53	22
Metformin Hcl	Metformin Hcl	53	19
Baclofen	Baclofen	50	21
Donepezil Hcl	Donepezil Hcl	47	12
Prednisone	Prednisone	45	27
Methylprednisolone	Methylprednisolone	43	31
Esomeprazole Magnesium	Esomeprazole Magnesium	42	11
Irbesartan	Irbesartan	42	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	41	suppressed
Jardiance	Empagliflozin	40	13
Ibandronate Sodium	Ibandronate Sodium	39	suppressed
Januvia	Sitagliptin Phosphate	38	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	38	suppressed
Famotidine	Famotidine	35	12
Potassium Chloride	Potassium Chloride	35	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	suppressed
Oxycodone Hcl	Oxycodone Hcl	32	suppressed
Glimepiride	Glimepiride	31	11
Pregabalin	Pregabalin	31	suppressed
Azithromycin	Azithromycin	30	22
Duloxetine Hcl	Duloxetine Hcl	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Alprazolam	Alprazolam	28	suppressed
Atenolol	Atenolol	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	28	11
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Clonazepam	Clonazepam	27	suppressed
Mounjaro	Tirzepatide	27	suppressed
Amoxicillin	Amoxicillin	26	11
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Colchicine	Colchicine	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	11
Finasteride	Finasteride	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	15
Trulicity	Dulaglutide	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Carvedilol	Carvedilol	19	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Chlorzoxazone	Chlorzoxazone	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Naproxen	Naproxen	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Valsartan	Valsartan	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	15
Dutasteride	Dutasteride	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Multaq	Dronedarone Hcl	16	suppressed
Nystatin	Nystatin	16	11
Ramipril	Ramipril	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Cephalexin	Cephalexin	15	14
Livalo	Pitavastatin Calcium	15	suppressed
Repaglinide	Repaglinide	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Bumetanide	Bumetanide	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Glipizide	Glipizide	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Cefuroxime	Cefuroxime Axetil	12	12
Diazepam	Diazepam	12	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Minocycline Hcl	Minocycline Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	11
Pitavastatin Calcium	Pitavastatin Calcium	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Etodolac	Etodolac	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Sulfasalazine	Sulfasalazine	11	suppressed
Tacrolimus	Tacrolimus	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error